Join Us

We are 218,228 members in 84 forums discussing 160,960 topics.

Help with Abbreviations

Topic: The HER2CLIMB-02 trial is enrolling (HER2-positive)

Forum: Clinical Trials, Research News, Podcasts, and Study Results —

Share your research articles, interpretations and experiences here. Let us know how these studies affect you and your decisions.

Posted on: Jun 23, 2020 09:40AM

Moderators wrote:

The HER2CLIMB-02 trial is enrolling people diagnosed with advanced-stage HER2-positive breast cancer:

The HER2CLIMB-02 trial (https://clinicaltrials.gov/ct2/show/NCT03975647) is looking to see if Tukysa (chemical name: tucatinib) given in combination with Kadcyla (chemical name: T-DM1 or ado-trastuzumab emtansine) will offer more benefits than Kadcyla alone in people diagnosed with:

  • metastatic HER2-positive breast cancer
  • locally-advanced HER2-positive disease that can't be completely removed with surgery
  • • a taxane chemotherapy, such as Taxotere (chemical name: docetaxel) or Taxol (chemical name: paclitaxel)
  • • Herceptin (chemical name: trastuzumab)

The HER2CLIMB-02 trial is being conducted at multiple sites around the world and the United States. For a complete list of sites, visit www.her2climb.com.

For more information on detailed eligibility requirements or to enroll

Visit the www.her2climb.com. You also may email clinicaltrials@seagen.com or call 1-866-333-7436.

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply